Clinical trial
Brain Imaging and Retreatment Study of Persistent Lyme Disease
NCT00037479 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00037479 |
|---|---|
| Title | Brain Imaging and Retreatment Study of Persistent Lyme Disease |
| Official title | PET and MRI Imaging of Persistent Lyme Encephalopathy |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lyme Disease, Lyme Neuroborreliosis |
| Intervention type | Drug |
| Interventions | ceftriaxone |
| Enrollment | 65 |
| Start date | Dec 1, 1999 |
| First posted | May 20, 2002 |
| Last update posted | Dec 7, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: